$AKTS
Aktis Oncology, Inc. Common stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AKTS up today? It is at $24.07 (+0.29%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AKTS spikes, and full due diligence on AKTS — key stats, earnings, dilution and insider activity. Free.
Get free $AKTS alerts the moment volume spikes
Our scanner flagged $AKTS 8 times in the last 30 days. Create a free account to track $AKTS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $24.07
- Change today
- +0.29%
- Previous close
- $24.00
- 52-week range
- $14.72 – $34.19
- Market cap
- $1.29B
- Shares outstanding
- 53.4M
- Total held
- 4.4%
- Tradeable float
- 51.1M 96% of shares · after 4% insiders + institutional n/a
- Short interest
- 3.5M ▼ -7% vs prior · as of 2026-07-31
- Short % of float
- 6.8%
- Days to cover
- 12.8d
- Avg daily volume
- 353K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 2.0x
- 15mthin
- 0.9x
- 1hthin
- 0.9x
- 1D
- --
Get free AKTS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $AKTS moving today?
Here is the latest on AKTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AKTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAktis Oncology, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling1 open-market buy0 buys, 4 sells last 3 months (13/4 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Herrmann Ken Director | Sold (automatic/other) | -5K | n/a | n/a | $119K at $24.56 | Jul 20, 26 |
Herrmann Ken Director | Other | 5K | n/a | 5K | $388 at $0.080 | Jul 20, 26 |
Herrmann Ken Director | Sold (automatic/other) | -3K | n/a | n/a | $77K at $25.21 | Jul 17, 26 |
Herrmann Ken Director | Other | 3K | n/a | 3K | $245 at $0.080 | Jul 17, 26 |
Czibere Akos Officer | Sold (automatic/other) | -50K 0.09% of company | n/a | n/a | $1.4M at $27.13 | Jul 8, 26 |
Czibere Akos Officer | Other | 50K 0.09% of company | n/a | 50K | $248K at $4.95 | Jul 8, 26 |
Ron-Bigger Shulamit Officer | Sold (automatic/other) | -50K 0.09% of company | n/a | n/a | $1.4M at $27.13 | Jul 8, 26 |
Ron-Bigger Shulamit Officer | Other | 50K 0.09% of company | n/a | 50K | $183K at $3.66 | Jul 8, 26 |
Segal Lloyd Mitchell Director | Acquired (grant/award) | +20K 0.04% of company | n/a | 20K | n/a | Jan 12, 26 |
Kim Helen Susan Director | Acquired (grant/award) | +4.99M 9.3% of company | n/a | 4.86M | n/a | Jan 12, 26 |
Kim Helen Susan Director | Bought (open market) | +835K 1.6% of company | added 17% | 5.83M | $15.0M at $18.00 | Jan 12, 26 |
Vida Ventures Ii, Llc Beneficial Owner (10%) | Acquired (grant/award) | +4.99M 9.3% of company | n/a | 4.86M | n/a | Jan 12, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $AKTS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $700.0M in size
- About $100.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$AKTS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$AKTS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to AKTS
Comparable names in pharmaceutical preparations, closest in size first.
AKTS stock FAQ
Why is $AKTS moving today?
Here is the latest on AKTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AKTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the AKTS stock price today?
AKTS last traded at $24.07, up 0.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live AKTS alerts?
The AKTS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AKTS 8 times in the last 30 days.
What exchange is AKTS on?
AKTS (Aktis Oncology, Inc. Common stock) trades on XNAS, with a market cap of about $1.29B in the PHARMACEUTICAL PREPARATIONS sector.
Is AKTS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AKTS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.